Statistics and Modelling for Health Sciences
Evaluation and Modeling with the Therapeutic Effects Group
Auffret Marine
Maîtresse de conférences - praticienne hospitalière
UCBL
Tel: 04 72 11 94 07
Publications
Display of 1 to 17 publications on 17 in total
Quelle place pour l’automatisation intelligente et l’intelligence artificielle pour préserver et renforcer l’expertise en vigilance devant l’augmentation des déclarations ?
Therapies . 78 ( 1 ) : 115-129
Journal article
see the publicationDPP-4 Inhibitors and Respiratory Infection: A Systematic Review and Meta-analysis of the Cardiovascular Outcomes Trials
Diabetes Care . 44 ( 3 ) : e36-e37
DOI: 10.2337/dc20-2018
Journal article
see the publicationEfficacy and safety of topiramate in binge eating disorder: a systematic review and meta-analysis
CNS Spectrums . 26 ( 5 ) : 459-467
Journal article
see the publicationA capture-recapture method for estimating the incidence of off-label prescriptions: the example of baclofen for alcohol use disorder in France
Thérapie . 74 : 645 - 650
Journal article
see the publicationClomiphene citrate and neural tube defects: a meta‐analysis of controlled observational studies
BJOG: An International Journal of Obstetrics and Gynaecology .
Journal article
see the publicationAuthors' reply to alain braillon's comment on
Drug Safety . 40 : 361-362
Journal article
see the publicationLes enjeux de sécurité de la prescription hors AMM : l’exemple du baclofène dans l’alcoolodépendance
Thesis
see the publicationThe dose–effect relationship of baclofen in alcohol dependence: A 1-year cohort study
Human Psychopharmacology. Clinical and Experimental . 32 ( 4 )
DOI: 10.1002/hup.2593
Journal article
see the publicationPhone-based safety monitoring of the first year of baclofen treatment for alcohol use disorder: the baclophone cohort study protocol
Expert Opinion on Drug Safety . 16 ( 2 ) : 125-132
Journal article
see the publicationProactive Regional Pharmacovigilance System Versus National Spontaneous Reporting for Collecting Safety Data on Concerning Off-Label Prescribing Practices: An Example with Baclofen and Alcohol Dependence in France
Drug Safety . 40 : 257-262
Journal article
see the publicationSafety and drinking outcomes among patients with comorbid alcohol dependence and borderline personality disorder treated with high-dose baclofen: a comparative cohort study
International Clinical Psychopharmacology . 30 ( 1 ) : 49-53
Journal article
see the publication[Drug Shortage May Have Serious Outcome: the French Exemple of Phenytoine].
Thérapie . 70 ( 4 ) : 377-80
Journal article
see the publicationBaclofen for alcohol dependence: relationships between baclofen and alcohol dosing and the occurrence of major sedation
European Neuropsychopharmacology . 25 : 1631-1636
Journal article
see the publicationDes ruptures de stock aux conséquences parfois graves : l’exemple de la phénytoïne, à propos de 7 cas
Thérapie . 70 ( 4 ) : 377-380
Journal article
see the publicationAttitudes of community pharmacists to off-label prescribing of baclofen in Northern France
International Journal of Clinical Pharmacy . 37 ( 2 ) : 296-299
Journal article
see the publicationTemporary Recommendation for Use on Off-label Baclofen: Viewpoint of Prescribers of the CAMTEA System
Thérapie . 70 ( 2 ) : 235-238
Journal article
see the publicationBullous pemphigoid induced by vildagliptin: a report of three cases
Fundamental & Clinical Pharmacology . 29 ( 1 ) : 112-114
DOI: 10.1111/fcp.12083
Journal article
see the publication